(lp0
S'Progenics Pharmaceuticals, Inc. to Participate in February Investor Conferences GlobeNewswire  - Feb 8, 2017 NEW YORK, Feb. 08, 2017  -- Progenics Pharmaceuticals, Inc. , an oncology company developing innovative medicines and other technologies for targeting and treating cancer, today announced that Mark Baker, Chief&nbsp;...'
p1
aS"What are Analyst's Indicators for Progenics Pharmaceuticals, Inc. (PGNX ... The USA Commerce - 18 hours ago Presently Progenics Pharmaceuticals, Inc.  stock have an ABR of 1.00. This is built on a simplified 1 to 5 scale where 1 represents a Strong Buy and 5 a Strong Sell."
p2
aS'Why Progenics Pharmaceuticals, Inc. Stock Climbed 76.5% in November Motley Fool - Dec 6, 2016 Shares of Progenics Pharmaceuticals, Inc. , a small biotech with an oncology focus, rocketed up 76.5% in November, according to data from S&amp;P Global Market Intelligence.'
p3
aS'Progenics Pharmaceuticals, Inc.  shows weekly volitility of 3.99% The Newburgh Press - 18 hours ago The 5 analysts offering 12-month price forecasts for Progenics Pharmaceuticals Inc have a median target of 13.00, with a high estimate of 14.00 and a low estimate of 11.00.Progenics Pharmaceuticals, Inc.  Announces Quarterly Earnings Results ... - Chaffey BreezeLatest Stocks: The Progenics Pharmaceuticals, Inc.  Position Raised by ... - Petro Global News 24'
p4
aS'Progenics Pharmaceuticals, Inc.  sitting close to a major resistance ... USA Commerce Daily - 16 hours ago With all other things going on, Progenics Pharmaceuticals, Inc.  has been on a run - rising 22.35 percent in just three months.'
p5
aS'Progenics Pharmaceuticals Announces Fourth Quarter and Full-Year 2016 ... GlobeNewswire  - Mar 9, 2017 NEW YORK, March 09, 2017  -- Progenics Pharmaceuticals, Inc.  today announced financial results and provided a business update for the fourth quarter and full-year 2016.'
p6
aS'Option Market Alert: Progenics Pharmaceuticals Inc Implied Price Swing Hits An ... CML News - Mar 19, 2017 Risk Alert: Before we dive into any analysis we simply note that Progenics Pharmaceuticals Inc  risk is elevated.'
p7
aS'Progenics Pharmaceuticals  in Focus: Stock Gains 8.3% Yahoo Finance - Feb 28, 2017 Progenics Pharmaceuticals PGNX was a big mover last session, as the company saw its shares rise above 8% on the day.Progenics Pharmaceuticals Inc.  Moves Higher on Volume Spike for February 28 - Equities.com'
p8
aS'Progenics Pharmaceuticals Inc.  Breaks into New 52-Week High on March 15 ... Equities.com - Mar 15, 2017 Shares of Progenics Pharmaceuticals Inc.  broke into a new 52-week high yesterday, hitting a peak of $11.72. Shares closed at $11.60 after opening at $11.25 for a move of 3.39%.Progenics Pharmaceuticals, Inc.  Expected to Post Q1 2017 Earnings of ... - Chaffey BreezeLatest Stocks: The Progenics Pharmaceuticals, Inc.  Expected to Post Q1 ... - Petro Global News 24'
p9
aS'With An ROE OF 10.4% In The Past Year, Can Progenics Pharmaceuticals Inc (PGNX ... Simply Wall St - Mar 6, 2017 Progenics Pharmaceuticals Inc  delivered 10.4% ROE over the past year, compared to 27.38% generated by its industry.Investors Reviewing Stock: Progenics Pharmaceuticals Inc.  - Is storiesRating Change on Progenics Pharmaceuticals Inc.  - Energy Index'
p10
a.